Ardelyx reported $4.81M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Amgen USD 1.87B 271M Jun/2026
Ardelyx USD 4.81M 6.04M Mar/2026
aTyr Pharma USD 1.31M 2.04M Mar/2026
Corcept Therapeutics USD 4.06M 1.18M Jun/2026
Curis USD 314K 9.96M Dec/2025
Sanofi EUR 3.14B 618M Mar/2026
TG Therapeutics USD 41.19M 7.68M Jun/2026
United Therapeutics USD 99.5M 33.9M Jun/2026